Lineage Cell Therapies: Director Grants 125,000 Options on Zero-Cost Basis, Signaling Strong Insider Confidence in Next‑Phase Growth
Lineage Cell’s insider option grant shows executive confidence in a rising biotech pipeline, hinting at future upside once clinical milestones hit.
- LINEAGE CELL THERAPEUTICS IN
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read
